BioRegen Biomedical specializes in the development of innovative biomedical materials aimed at enhancing tissue repair and regeneration, particularly in the fields of gynecology (GYN) and ear, nose, and throat (ENT) medicine. Their product line includes HyaRegen Gel, an absorbable adhesion barrier designed to prevent post-surgical adhesions, and MateRegen Gel, which serves as an intrauterine adhesion barrier. Additionally, they offer PureRegen Gel, specifically formulated for use in nasal and sinus dressings. These products are designed to address various medical challenges and improve patient outcomes in surgical settings.

The company is committed to research and development, production, and sales of these advanced materials, with a focus on meeting the needs of clinical departments in both domestic and international markets. BioRegen has successfully expanded its reach since launching overseas sales channels in 2014, distributing its products across Asia, Europe, the Americas, and the Middle East. Their dedication to quality is underscored by recent certifications in environmental management and occupational health and safety, reflecting their commitment to both innovation and responsible business practices.

China

BioRegen is specialized in innovative and novel therapeutic biomaterials and regenerative medicine. Based on its unique and proprietary "self-crosslinking" technology platform, the company has developed several products - HyaRegen Gel , MateRegen Gel and PureRegen Gel for broad clinical application such as general surgery, GYN/OB and ENT surgeries and launched in many countries over the world. The gel can prevent postsurgical adhesion and promote the intimal regeneration.

Regenerative medicine

Floors 17-22, Building 3, Aerospace City Central Plaza, No. 666 East Chang'an Street, National Civil Aerospace Industry Base

BioRegen Biomedical

Company Details